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ABSTRACT 
Leiomyosarcoma is one of the soft tissue sarcomas that could originate from different parts of body and are 
mostly presented as retropritoneal mass. Leiomyosarcomas of vascular origin are particularly rare tumors 
occurring mainly in inferior vena cava (IVC). Here, we report the case of a 35-year-old male patient who 
presented with ascites and jaundice. Further evaluation revealed large hepatic and cardiac masses with 
extension to IVC. Since it was not possible to determine the point of origin of leiomyosarcoma, the patient 
received chemotherapy under diagnosis of metastatic leiomyosarcoma but unfortunately passed away. 
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INTRODUCTION 
   Leiomyosarcomas, which are characterized by 
smooth muscle differentiation, can be found 
throughout the body including the retroperitoneum 
and any location where there is a vein.1 The 
presentation of the tumor is different, depending 
on the site and origin of the tumor. Mostly presents 
as a large retropritoneal mass and the involvement 
of IVC but cardiac chambers are extremely rare. 
Here, we report a case presented with inferior vena 
cava (IVC) mass associated with hepatic and right 
atrium tumors. 
 
CASE PRESENTATION 
   A 35-year-old male patient presented with 
abdominal and lower extremity swellings. He stated 
that abdominal swelling started 15 days ago and 
then he observed an increase in the swelling. 
Meanwhile, six days before admission, he noticed 
swelling in both legs. He also complained of 
jaundice, dyspnea on exertion, loss of appetite and 
malaise. Abdominal ultrasound was performed and 
revealed severe ascites, splenomegaly and a 
hypoecho mass in the right liver lobe with extension 
to midline. On physical examination, the patient 
was conscious and a generalized icterus was seen. 
Abdominal distention, bilateral decreased breath 
sounds in basilar lung regions and pitting edema of 
both lower extremities were detected but the 
remainder of examination was normal. 
On evaluation, ascitic fluid analysis revealed the 
high serum-ascites albumin gradient (SAAG) fluid 
and triphasic abdominal computed tomography (CT) 
confirmed a large mass in the right liver lobe with 
changes in inferior vena cava (IVC) and hepatic veins 
suggestive of tumor extension or thrombosis 
(Figures 1, 2). Doppler ultrasound of hepatic and 
portal veins showed no thrombosis.  
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For further evaluation of generalized edema and 
cardiac function, transthoracic echocardiography 
was done and showed a large mass 40*40 
millimeters in the right atrium and small pericardial 
effusion. Laboratory tests were remarkable for 
abnormal liver function test in hepatocellular 
pattern and prolonged prothrombin time (PT) in 
association with hypochrome microcytic anemia 
(Table 1). 
Femoral vein catheterization was done to try biopsy 
of IVC mass, femoral vein catheterization was done 
to perform IVC mass biopsy but tortuous course of 
IVC made it impossible. Due to the location of 
hepatic mass, transjugular or percutaneous liver 
biopsy was not possible. So, CT-guided biopsy from 
IVC mass was performed. Pathologic examination 
and immunohistochemistry study revealed high 
grade leiomyosarcoma (Figure 3, 4, 5). 
The patient received chemotherapy regimen 
including gemcitabine and docetaxel under 
diagnosis of metastatic leiomyosarcoma. Due to 
tumor extension, patient was not a suitable 
candidate for surgery or radiotherapy; so, 
chemotherapy continued. He then developed 
hepatic encephalopathy and liver failure during 
hospitalization and unfortunately passed away. First 
degree relative of patient had given a written 
consent for publishing information. 
 
DISCUSSION 
   Sarcomas are rare and heterogeneous group of 
malignant tumors of mesenchymal origin that 
comprise approximately 1 % of all adult 
malignancies. Approximately, 80 % of sarcomas 
originate from soft tissue and the rest from bone.1 
The WHO classifies most soft tissue sarcomas 
according to presumptive tissue of origin that one 
of them is leiomyosarcoma.2 Leiomyosarcomas, 
which are characterized by smooth muscle 
differentiation, can be found throughout the body 
including the retroperitoneum, any location where 
there is a vein and the uterus. The most common 
presentation is an asymptomatic mass. Mechanical 
symptoms referable to pressure, traction, or 
entrapment of nerves or muscles may also be 
present. 
 
Figure 1: Pleomorphic, plump, spindle and polyhedral cells arranged as 
short bundles and fascicles with capillary-sized vascular channels 
between them .The tumor cells show nuclear-to- cytoplasmic ratio with 
moderate nuclear pleomorphism and hyperchromasia. Cytoplasmic 
borders are indistinct (Hematoxylin and Eosin, X100). 
 
 
   Figure 2: Tumor cells show diffuse cytoplasmic reactivity with Anti-
Actin (muscle) (Clone: HHF35, monoclonal Mouse Anti-Human, X100). 
 
 
 
Figure 3: High proliferation capacity of tumor cells demonstrated by 
staining with anti-Ki67 Antigen (Clone: MIB-1 monoclonal mouse anti-
human, X100). 
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Figure 4: Contrast-enhanced chest computed tomography revealed 
large heterogeneous mass in right atrium (black arrow) and bilateral 
pleural effusion. 
 
 
Figure 5: Contrast-enhanced abdominal computed tomography showed 
extension of the mass to IVC (black arrow) and ascitis. 
 
This case demonstrates the difficulty in 
distinguishing the origin of the tumor and its 
uncommon presentations. As we mentioned above, 
our patient presented with ascites and jaundice and 
further evaluation revealed IVC mass associated 
with hepatic and cardiac tumors. Leiomyosarcoma 
of the inferior vena cava (IVC) is the most common 
primary malignancy of the IVC and has an extremely 
poor prognosis.3 The most common presenting 
symptom is a pain in the right flank and other 
presentations are edema of the lower extremities, 
Budd-Chiari syndrome with hepatomegaly, ascites, 
and jaundice.4,5 Systemic metastasis occurs in less 
than 50 percent of patients in late stages and most 
common sites are liver, lung, lymph nodes or bone6 
and propagation of the tumor to right atrium occurs 
in less than 20 percent of patients.7 
Metastatic soft tissue sarcomas are largely 
incurable but up to 20% of patients who achieve a 
complete response become long-term survivors. 
The therapeutic intent, therefore, is to produce a 
complete remission with chemotherapy (<10%) 
and/or surgery (30–40%) although the efficacy of 
chemotherapy and radiotherapy is extremely low in 
leiomyosarcoma.8 Surgical resection of metastases, 
whenever possible, is an integral part of the 
management. The two most active 
chemotherapeutic agents are doxorubicin and 
ifosfamide. Gemcitabine with or without docetaxel 
has become an established second-line regimen and 
is particularly active in patients with 
leiomyosarcoma.9,10 
 
 
Table 1: Laboratory tests 
Variable  On 
admission 
Variable On 
admission 
Variable On 
admission 
WBC 5600 ALP  370  INR 2.2 
Hb 13.1 Bili Total 6 AFP 1.3 
Platelet  154000 Bili Direct 2.1 Β-hCG  <1 
Ferritin   Serum Alb  3.1 ESR  50 
AST  167 Creatinine  1.2 CRP  62 
ALT  182 LDH  471   
 
CONCLUSION 
   Since leiomyosarcoma of vascular origin is an 
uncommon finding and metastasis to heart 
chambers is even more uncommon, we aimed to 
report this rare presentation of sarcomas of 
vascular origin. 
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